MedPath

Angiopoietin-like protein 8 (ANGPTL8) Levels in Thai Hyperalphalipoproteinemic Patients

Not Applicable
Recruiting
Conditions
ANGPTL8 level in hyperalphalipoproteinemic patientspost prandial ANGPTL8 level in hyperalphalipoproteinemic patients
Registration Number
TCTR20170224001
Lead Sponsor
Ratchadaphiseksomphot Endowment Fund
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
24
Inclusion Criteria

Have at least 2 episodes of hyperalphalipoproteinemia defined as HDL-C level more than 100 mg/dl

Exclusion Criteria

chronic alcohol assumption more than 0.5 g/kg of body weight
nephrotic syndrome
end stage renal disease with renal replacement therapy
cirrhosis
receiving HMG CoA reductase inhibitor, fenofibrate, insulin, estrogen, niacin, steroid, and phenytoin
pregnancy and lactating

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
ANGPTL8 level in Thai hyperalphalipoproteinemicpatients once at measured time ELISA
Secondary Outcome Measures
NameTimeMethod
post prandial ANGPTL8 level in Thai hyperalphalipoproteinemic patient 2 hous postprandial ELISA
© Copyright 2025. All Rights Reserved by MedPath